ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2025

Safety and clinical activity of BMS-986365 (CC-94676), a dual androgen receptor ligand-directed degrader and antagonist, in heavily pretreated patients with metastatic castration-resistant prostate cancer.

D E Rathkopf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.